Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Chd industries await new policy Implementation
Industrialists say lack of policy guidelines affecting growth.

Kalam advises Isro, Nasa on Chandrayaan-II
The Indian Space Research Organisation (Isro) and US space agency Nasa should deploy surface robotic penetrator in "Chandrayaan-II" mission to study more about the presence of water molecules on moon, former President APJ Abdul Kalam has suggested.

News of the day

Govt to spend Rs 15,000 cr for 'a clean, free-flowing Ganga'
The Centre has expressed confidence that by 2020 the polluted river Ganga would be cleaned and Rs 15,000 crore will be spent on it.
Public Company

GSK to launch 'promecta' in India by 2009-end

Glaxo SmithKline Pharmaceutical today said it is looking at launching its patented medicine promecta, used in treatment of depleted platelet count, in India by this year-end or early next year. - Aurobindo Pharma receives Swissmedic approval for cefepime for injection - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Sun Pharma invalidates Eli Lilly"s Gemzar patent - Glenmark"s drug fails clinical trials - Aurobindo Pharma to acquire Trident Life Sciences "We are looking to launch our promecta in the Indian market in the fourth quarter of this year or in the first quarter of next year," GSK Vice President South Asia and Managing Director India Hasit Joshipura told reporters on the sidelines of a function here. When asked if the company has got drug regulator DCGI nod for launching the medicine here, he said, "We have applied for the regulatory approval but we haven"t got it yet. But we hope to get it by the end of this year of early next year."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009